Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene

Journal of Cellular Physiology

Volumn 208, Issue 2, 2006, Pages 326-335

  Nakayama, Youhei ^a   Nakajima, Yu ^a   Kato, Naoko ^a   Takai, Hideki ^a   Kim, Dong Soon ^a   Arai, Masato ^a   Mezawa, Masaru ^a   Araki, Shouta ^a   Sodek, Jaro ^b   Ogata, Yorimasa ^a  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTIBODY; BONE SIALOPROTEIN; FIBROBLAST GROWTH FACTOR 2; FRE PROTEIN; HOMEODOMAIN PROTEIN; HOX PROTEIN; PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; SIALOPROTEIN; SMAD1 PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX2; TRANSCRIPTION FACTOR DLX5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; BENZOQUINONES; BINDING SITES; BONE MARROW CELLS; BUTADIENES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CLONE CELLS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LACTAMS, MACROCYCLIC; MUTATION; NITRILES; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); QUINONES; RATS; RESPONSE ELEMENTS; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC;

EID: 33745598167     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20664     Document Type: Article

References (61)

1. Asta P, Tiina J, Pekka HM. 1993. Insulin-like growth factor-I modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells. Eur J Biochem 218:883-891.
2. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC. 2003. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and Msx2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631-2637.
3. Benson MD, Aubin JE, Xiao G, Thomas PE, Franceschi RT. 1999. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J Bone Miner Res 14:396-405.
4. Benson MD, Bargeon JL, Xiao G, Thomas PE, Kim A, Cui Y, Franceschi R. 2000. Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression. J Biol Chem 275:13907-13917.
5. Borgatti P, Martelli AM, Bellacosa A, Casto R, Massari L, Capitani S, Neri LM. 2000. Translocation of Akt-PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 477:27-32.
6. Chen JK, Shapiro HS, Sodek J. 1992. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997.
7. Delany AM, Pash JM, Canalis E. 1994. The role of insulin-like growth factors and binding proteins in bone cell biology. J Cell Biochem 55:328-333.
8. Dignam JD, Lebovitz RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 11:1475-1489.
9. Dong Y, Canalis E. 1995. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 136:2000-2006.
10. Drissi MH, Li X, Sheu TJ, Zuscik MJ, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. 2003. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem 90:1287-1298.
11. Ducy P, Karsenty G. 1995. Two distinct osteoblast-specific cis-acting element control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
12. Favata MF, Horinouchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyke DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskoa JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
13. Franke TF, Kaplan DR, Cantley LC. 1997. Downstream AKT ion blocks apoptosis. Cell 88:435-437.
14. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T. 2004. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3-Akt signaling. J Cell Biol 166:85-95.
15. Ganss B, Kim RH, Sodek J. 1999. Bone sialoprotein. Crit Rev Oral Biol Med 10:79-98.
16. Ghosh CN, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. 2002. Requirement of BMP-2 induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-33368.
17. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271:695-701.
18. Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A. 2003. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci 8:1249-1265.
19. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
20. Hunter GK, Goldberg HA. 1993. Nucleation of hydroxyapatite by bone sialoprotein, Proc Natl Acad Sci USA 90:8562-8565.
21. Jensen DE, Rich CB, Terpstra AJ, Farmer SR, Foster JA. 1995. Transcriptional regulation of the elastin gene by insulin-like growth factor-I involves disruption of Sp1 binding. Evidence for the role of Rb in mediating Sp1 binding in aortic smooth muscle cells. J Biol Chem 270:6555-6563.
22. Ji C, Chang W, Centrella M, McCarthy TL. 2003. Activation domains of CCAAT enhancer binding protein delta: Regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor-I gene expression in rat osteoblasts. Mol Endocrinol 17:1834-1843.
23. Kaliman P, Vinals F, Tester X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271:19146-19151.
24. Kerr JM, Fisher LW, Termine JD, Wang MG, Mcbride OW, Young MF. 1993. The human bone sialoprotein gene (IBSP): Genomic localization and characterization. Genomics 17:408-415.
25. Kim RH, Sodek J. 1999. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res 59:565-571.
26. Kim RH, Shapiro HS, Li JJ, Wrana JL, Sodek J. 1994. Characterization of human bone sialoprotein (BSP) gene and its promoter sequence. Matrix Biol 14:31-40.
27. 3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene. Biochem J 318:219-226.
28. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamaoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblast. Cell 89:755-764.
29. Kveiborg M, Flybjerg A, Eriksen EF, Kassem M. 2001. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169:549-561.
30. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyong HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM. 2003. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278:34387-34394.
31. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Re 16:143-163.
32. Li JJ, Sodek J. 1993. Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem J 289:625-629.
33. Li JJ, Kim RH, Sodek J. 1995. An inverted TATA box directs downstream transcription of the bone sialoprotein gene. Biochem J 310:33-40.
34. Martelli AM, Borgatti P, Bortul R, Manfredini M, Massari L, Capitani S. 2000. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor α. J Bone Miner Res 15:1716-1730.
35. Merriman HL, La TD, Linkhart TA, Mohan S, Baylink DJ, Strong DD. 1990. Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells. Calcif Tissue Int 46:258-262.
36. Middleton J, Arnott N, Walsh S, Beresford JN. 1995. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type I IGF receptor. Bone 16:287-293.
37. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ. 1995. Studies on the mechanisms by which insulin-like growth factor-I (IGF-I) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431.
38. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for ostoblast differentiation and bone formation. Cell 108:17-29.
39. Nakayama Y, Kato N, Nakajima Y, Shimizu E, Ogata Y. 2004. Effect of TNF-α on human osteosarcoma cell line Saos2-TNF-α regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells. Cell Biol Int 28:653-660.
40. Newberry EP, Latifi T, Towler DA. 1998. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37:16360-16368.
41. Ogata Y, Yamauchi M, Kim RH, Li JJ, Freedman LP, Sodek J. 1995. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression: Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 230:183-192.
42. Ogata Y, Niisato N, Furuyama S, Cheifetz S, Kim RH, Sugiya H, Sodek J. 1997. Transforming growth factor-β1 regulation of bone sialoprotein gene transfection: Identification of a TGF-β activation element in the BSP gene promoter. J Cell Biochem 65:501-512.
43. Ogata Y, Nakao S, Kim RH, Li JJ, Furuyama S, Sugiya H, Sodek J. 2000. Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter. Matrix Biol 19:395-407.
44. Oldberg Å, Franzén A, Heinegård D. 1988. The primary structure of a cell-binding bone sialoprotein. J Biol Chem 263:19430-19432.
45. Parson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
46. Peng XD, Xu PZ, Chen ML, Harn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365.
47. Pitaru S, Kotev-Emeth S, Noff D, Kaffuler S, Savion N. 1993. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res 8:919-929.
48. Ryoo HM, Hoffmann HM, Beumer T, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijmen AJ, Lian JB. 1997. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11:1681-1694.
49. Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, Spiegelman BM, Kasuga M. 1998. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273:28945-28952.
50. Samoto H, Shimizu E, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2002. TNF-α suppresses bone sialoprotein (BSP) expression in ROS17/2.8 Cell. J Cell Biochem 87:313-323.
51. 2 stimulates bone sialoprotein (BSP) expression through cAMP and FGF2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 278:28659-28667.
52. Shimizu E, Ogata Y. 2002. Activation of bone sialoprotein gene transcription by flavonoids is mediated through an inverted CCAAT box in ROS 17/2.8 cells. J Cell Biochem 86:35-44.
53. Shimizu E, Matsuda-Honjyo Y, Samoto H, Saito R, Nakajima Y, Nakayama Y, Kato N, Yamazaki M, Ogata Y. 2004a. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif. J Cell Biochem 91:1183-1196.
54. Shimizu E, Nakajima Y, Kato N, Nakayama Y, Saito R, Samoto H, Ogata Y. 2004b. Regulation of rat bone sialoprotein (BSP) gene transcription by enamel matrix derivative. J Periodontol 75:260-267.
55. Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2001. Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP. J Biol Chem 276:5459-5466.
56. Simeone A, Acampora D, Pannese M, D' Esposito M, Stornaiuolo A, Gulisano M, Mallamaci A, Kastury K, Druck T, Huebner K, Boncinelli E. 1994. Cloning and characterization of two members of the vertebrate Dlx gene family. Proc Natl Acad Sci USA 91:2250-2254.
57. Waltregny D, Bellahcène A, Leval XD, Florkin B, Weidle U, Castronovo V. 2000. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 15:834-843.
58. Yamauchi M, Ogata Y, Kim RH, Li JJ, Freedman LP, Sodek J. 1996. AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter. Matrix Biol 15:119-130.
59. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. 2002a. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
60. Zhang X, Sobue T, Hurlev MM. 2002b. FGF-2 increases colony formation, PTH receptor, and IGF-I mRNA in mouse marrow stromal cells. Biochem Biophys Res Commum 290:526-531.
61. Zhang K, Chen J, Wang M, Wang C, Li G, Zheng Z, Zhao R. 2003. The expression insulin-like growth factor-I mRNA and polypeptide in rat osteoblast with exposure to parathyroid hormone. Chin Med J 116:1916-1922.